SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-26-044747 from Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience, Inc.
Date: April 17, 2026 · CIK: 0001999480 · Accession: 0001104659-26-044747

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-294974

Date
April 17, 2026
Author
Nicholas C. Smith
Form
CORRESP
Company
Alto Neuroscience, Inc.

Letter

A lto Neuroscience , Inc.

650 Castro Street, Suite 450 Mountain View, CA 94041

April 17, 2026

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Lauren S. Hamill

Re: A lto Neuroscience, Inc.

Registration Statement on Form S-3 (File No. 333-294974)

Request for Acceleration of Effective Date

Ms. Hamill,

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the " Registrant ") hereby requests that the Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-294974) (the " Registration Statement ") to become effective on April 20, 2026, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such other time as the Registrant or its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission. The Registrant hereby authorizes each of Courtney M.W. Tygesson and Madison A. Jones of Cooley LLP to make such a request on its behalf.

Once the Registration Statement has been declared effective, please confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680 or ctygesson@cooley.com, or in her absence, Madison A. Jones, at (202) 728-7087 or madison.jones@cooley.com.

[Signature page follows]

Very truly yours,
Alto Neuroscience, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 A lto
Neuroscience , Inc.

 650 Castro Street, Suite 450
Mountain View, CA 94041

 April 17, 2026

 Via EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, D.C. 20549

 Attn:
 Lauren S. Hamill

 Re:
 A lto Neuroscience, Inc.

 Registration Statement on Form S-3 (File No. 333-294974)

 Request for Acceleration of Effective Date

 Ms. Hamill,

 In accordance with Rule 461 under the Securities Act of 1933, as amended,
the undersigned registrant (the " Registrant ") hereby requests that the Securities and Exchange Commission (the
" Commission ") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File
No. 333-294974) (the " Registration Statement ") to become effective on April 20, 2026, at 4:00 p.m. Eastern Time,
or as soon thereafter as is practicable, or at such other time as the Registrant or its legal counsel, Cooley LLP, may request by telephone
to the staff of the Commission. The Registrant hereby authorizes each of Courtney M.W. Tygesson and Madison A. Jones of Cooley LLP to
make such a request on its behalf.

 Once the Registration Statement has been declared effective, please
confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680 or ctygesson@cooley.com, or
in her absence, Madison A. Jones, at (202) 728-7087 or madison.jones@cooley.com.

 [Signature page follows]

 Very truly yours,

 Alto Neuroscience, Inc.

 By:
 /s/ Nicholas C. Smith

 Nicholas C. Smith

 Chief Financial Officer

 cc:

 Amit Etkin, M.D., Ph.D., Alto Neuroscience, Inc.
 Erin R. McQuade, Alto Neuroscience, Inc.
 Divakar Gupta, Cooley LLP

 Courtney M.W. Tygesson, Cooley LLP

 Madison A. Jones, Cooley LLP

 Signature Page to Company Acceleration Request
– S-3